The product is disappearing into reorder rhythm: revenue is shifting from won-each-time to arriving-on-its-own, and the
The model's full reasoning — Q2 2021 call → NOWe need answer only YES or NO. Need analyze transcript. Question asks: Does management describe that a growing share of company's revenue now arrives without a new selling event — through reorders, refills, renewals, repeat purchases, usage-driven billing, aftermarket or consumable pull-through, or customers' own standing routines — AND that this self-arriving share has recently and visibly grown as proportion of business, with management grounding shift in observed current behavior and treating it as changing quality of revenue? Need use only transcript. Need determine if management describes such. The business is diagnostic testing. Revenue from tests. Is there self-arriving revenue? Maybe base business recovery, consumer initiated testing, health plan contracts, value-based programs. But question specifically about recurring revenue without new selling event. In transcript, management talks about base business recovery, people returning to health care, organic base testing revenues grew. They talk about health plan contracts, Aetna renewal, value-based programs. But is there a description of self-arriving revenue growing as proportion? Not really. They talk about COVID testing, base business recovery. They mention "consumer initiated testing revenues continued to grow" with MyQuest app. But that's not necessarily self-arriving without selling event? It's patients initiating. But no mention of reorders, renewals, consumable pull-through. They mention "renewed our longstanding contractual relationship with Aetna" but that's a contract renewal, not self-arriving revenue without selling event. Also "repeat behavior" not discussed. The question is specific to business model where revenue arrives without new selling event. This transcript is about Quest Diagnostics, lab testing. Revenue is from tests ordered by physicians/patients. Not a recurring revenue model. Management does not describe a shift to self-arriving revenue. They discuss recovery of base business, COVID testing, investments. No mention of installed base scaling, consumable stream, etc. So answer NO. Need ensure no hidden. They mention "base consumer initiated testing revenues continued to grow" - but that's not self-arriving? It's patients choosing to test, but still each test is a sale. No mention of proportion shift. Also "value based programs" with payers, but not self-arriving. So NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| DUOT | Duos Technologies Group, Inc. | Q4 2023 | 2024-04-01 | F |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| IRBT | iRobot Corporation | Q3 2021 | 2021-10-28 | D |
| TOUR | Tuniu Corporation | Q4 2017 | 2018-03-14 | D |
DUOT · Q4 2023 → YESThe question is about whether management describes a growing share of revenue arriving without a new selling event, through reorders, renewals, etc., and that this has recently and visibly grown as a ...
QTRX · Q3 2023 → YESThe question is about whether management describes a growing share of revenue arriving without a new selling event, like through reorders, consumables, etc., and that this share has recently grown.
CYBR · Q3 2021 → YESThe question is about whether management describes a growing share of revenue arriving without a new selling event, like through renewals, and that this has recently grown as a proportion.